Actively Recruiting

Phase 2
Age: 60Years - 90Years
All Genders
NCT07143734

Transcranial Pulse Stimulation for Alzheimer's Disease

Led by Chinese University of Hong Kong · Updated on 2025-09-16

40

Participants Needed

1

Research Sites

45 weeks

Total Duration

On this page

Sponsors

C

Chinese University of Hong Kong

Lead Sponsor

A

Asia Pacific Institute of Healthy ageing

Collaborating Sponsor

AI-Summary

What this Trial Is About

TPS is a non-invasive therapeutic modality that uses focused, low-energy pulse stimulation to stimulate tissue regeneration and reduce inflammation. In the context of neurological disorders, it is hypothesized that TPS can modulate neuronal activity, enhance synaptic plasticity, and reduce neuroinflammation. It is a relatively new application in neurological disease treatment and is still under intense investigation.

CONDITIONS

Official Title

Transcranial Pulse Stimulation for Alzheimer's Disease

Who Can Participate

Age: 60Years - 90Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults clinically diagnosed with early-stage Alzheimer's Disease (stage 2-6a by Functional Assessment Staging Test)
  • Have mental capacity to give informed consent as assessed by a geriatrician
  • Aged between 60 and 90 years old
  • Able to give informed consent with assistance, witnessed and signed by a family caregiver
Not Eligible

You will not qualify if you...

  • Cannot understand Chinese
  • Mentally incapacitated or unable to provide informed consent
  • Unable to remain still for 30 minutes
  • No available family caregiver to answer questionnaires
  • Alcohol or substance dependence
  • Major neurological conditions such as brain tumor or brain aneurysm
  • Presence of metal implants in the brain
  • Hemophilia or other blood clotting disorders
  • History of thrombosis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese UNiversity of Hong Kong

Hong Kong, Hong Kong

Actively Recruiting

Loading map...

Research Team

K

KI SUM CHU, PhD candidate

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here